Waiver allows pathologists to work remotely during pandemic

By LabPulse.com staff writers

March 27, 2020 -- The College of American Pathologists (CAP) announced that its lobbying efforts with the federal government have been successful in allowing pathologists to work remotely during the COVID-19 pandemic.

Through a waiver, pathologists have regulatory flexibility in terms of where they work, with temporary relief from the CLIA regulations, which require pathologists to perform diagnostic tests at certified facilities.

Consistent with what's been done during other health emergencies, the U.S. Centers for Medicare and Medicaid Services (CMS) will also exercise enforcement discretion when it comes to the CLIA regulation requiring that cytology slide preparations be evaluated on the premises of a laboratory certified to conduct testing in the subspecialty of cytology. The agency will not enforce the regulation that requires a separate certificate for laboratories that are located at temporary testing sites. This will not be enforced if the designated primary site or home base has a CLIA certificate and the work being performed at the temporary sites falls within the parameters of the primary site's certificate.

CAP cancels leadership summit
Amid the coronavirus pandemic, the College of American Pathologists (CAP) has canceled its Leadership Summit and House of Delegates meeting, which was...
CAP suspends facility accreditation inspections
In response to the coronavirus pandemic, the College of American Pathologists (CAP) has suspended most U.S. facility accreditation inspections for at...
CAP seeks comment on guidelines for immunotherapy biomarker testing
The College of American Pathologists (CAP) is seeking comments on new draft guidelines governing testing for DNA mismatch repair and microsatellite instability,...
CAP survey shows strong demand for pathologists -- at least for now
Demand for pathologists in the U.S. is strong, contrary to some negative reports, according to a survey of practices by the College of American Pathologists...
CAP, ASCO weigh in on handling ER-low-positive breast cancers
Updated guidance from the College of American Pathologists (CAP) and American Society of Clinical Oncology (ASCO) on estrogen and progesterone receptor...

Copyright © 2020 LabPulse.com

Last Updated eh 3/30/2020 1:08:22 PM